Biggest News
Trade These, Not Those: Capital Rotation in Motion as Blade, Kraig, Psyence, and Verb Redefine the Small-Cap Narrative
DENVER, Colo., Aug 04, 2025 (247marketnews.com)- In a market still dominated by rate headlines and ETF-driven flows, the most interesting money is chasing transformation. Trade These: Joby (NYSE:JOBY) and Blade…
INmune Bio’s INKmune CaRe PC Trial in Metastatic Castration-Resistant Prostate Cancer Meets Endpoints
DENVER, Colo., Aug 04, 2025 (247marketnews.com)- INmune Bio’s (NASDAQ:INMB) Phase I/II clinical trial of INKmune, the CaRe PC trial, in patients with metastatic castration-resistant prostate cancer (mCRPC) has successfully met…
Blade Sells Passenger Division to Joby Aviation for Up to $125M
DENVER, Colo., Aug 04, 2025 (247marketnews.com)- Blade Air Mobility (NASDAQ:BLDE) entered into a definitive agreement to sell its passenger business to Joby Aviation (NYSE:JOBY) for up to $125 million, transitioning…
Closing Bell Heat Check: Biotech Breakouts, Reverse Mergers & Moonshot Setups Heading into After-Hours
DENVER, Colo., Aug 01, 2025 (247marketnews.com)- As the final trading hour approaches, watch for names building into potential breakouts, or setting up for extended moves after-hours. 4D Molecular (NASDAQ:FDMT) is…
Trade These, Not Those: Capital is Rotating and Here’s Where It’s Headed
DENVER, Colo., Aug 01, 2025 (247marketnews.com)- While the major indices grind sideways, traders are finding alpha in small- and mid-cap catalysts and this week, the opportunities are flashing across biotech,…
10 Reasons Siyata Mobile Is a Perfect Match for Core Gaming
DENVER, Colo., Aug 01, 2025 (247marketnews.com)- Siyata Mobile (NASDAQ:SYTA), a global developer and vendor of mission-critical Push-to-Talk over Cellular (PoC) handsets and accessories, continues to advance its $185 million merger…
BioXcel Therapeutics Completes Last Patient Visit in Key Phase 3 SERENITY At-Home Trial for Acute Agitation in Bipolar Disorder and Schizophrenia
DENVER, Colo., Aug 01, 2025 (247marketnews.com)- BioXcel Therapeutics (NASDAQ:BTAI) completes the last patient last visit (LPLV) in its pivotal Phase 3 SERENITY At-Home clinical trial. The trial is evaluating the…
Gaming Industry’s Revenue Surge Signals Evolving Landscape and Investor Reawakening
DENVER, Colo., Jul 31, 2025 (247marketnews.com)- Despite lingering macroeconomic uncertainty, the gaming sector is flashing signals of resilience and, in some cases, reinvention. From traditional publishers to mobile-first adtech disruptors,…
Trade These, Not Those: Where Smart Money’s Moving on Psychedelics, Live Entertainment, and More
DENVER, Colo., Jul 31, 2025 (247marketnews.com)- Two under-the-radar tickers are catching fire for their fundamentals and future-facing narratives: Psyence Biomedical (NASDAQ:PBM) and Venu (NYSE:VENU). Psyence reported a major milestone through…
Psyence BioMed and PsyLabs Achieve Major Milestone in High-Purity Ibogaine Production
DENVER, Colo., Jul 31, 2025 (247marketnews.com)- Psyence Biomedical (NASDAQ:PBM) reported that its strategic partner, PsyLabs, produced a GMP-aligned Ibogaine Total Alkaloid (TA) extract that meets all microbial safety standards for…